Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 5, 2021, after the close
10-Q filed Aug 5, 2021, 36 days after period end · 0000320017-21-000100
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$5.68M | $6.60M | -$5.14M | -$4.08M |
| EPS Diluted | -$0.10 | $0.50 | -$0.49 | -$0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
